UC Davis Health biophysical chemist Robert Fairclough’s lab has developed a molecule that could generate a better diagnostic test and therapies for the autoimmune disease myasthenia gravis.
Read MoreFemale and male hearts respond differently to “fight or flight” stress hormone, according to a new UC Davis study in mice. It may help explain sex differences in arrhythmia risk.
Read MoreUC Davis rehabilitation specialists tested a 3D markerless motion analysis technology’s ability to identify potential neurological conditions and monitor disease progression in patients in community settings.
Read MoreThe Interventional Pulmonology Program has completed its 100th robotic-assisted bronchoscopy procedure for minimally invasive peripheral lung biopsy, becoming the first hospital in the Sacramento region to reach this milestone.
Read MoreOphthalmologist Glenn Yiu received a $2 million grant from the UC Office of the President to lead a remote ophthalmology program with UCLA, UCSD and UCSF to increase eye screenings for underserved people with diabetes.
Read MoreThe UC Davis Health Spine Center is leading a clinical trial seeking treatments that could give people disabled by severe spinal cord injuries more independence.
Read MoreAn American College of Surgeons quality improvement program reduced surgical wait times and cut hospital stays by more than a day.
Read MoreUC Davis Health has received a $25 million grant to continue the Life After 90 study. The research is identifying factors that contribute to brain health and dementia in a diverse population.
Read MoreA new study looks at cancer deaths in California due to tobacco, sounding the alarm regarding the tragic loss of life caused by tobacco addiction.
Read MoreUC Davis Health surgeons find FLIm, a novel optical imaging system, helpful in detecting primary cancer cells in head and neck cancer of unknown origin.
Read MoreThe Interventional Pulmonology Program has completed its 100th robotic-assisted bronchoscopy procedure for minimally invasive peripheral lung biopsy, becoming the first hospital in the Sacramento region to reach this milestone.
Read MoreUC Davis Health welcomed the first patients to the new Ernest E. Tschannen Eye Institute on Monday, Dec. 5.
Read MoreA new UC Davis MIND Institute study finds the NIH Toolbox Cognition Battery is a promising option for measuring cognitive change in people with intellectual disability.
Read MoreA polymer-based microshunt is safe and effective in pediatric patients with refractory childhood glaucoma, according to a small, single-center case series at the UC Davis Health Eye Center. The children in the study needed trabeculectomy or implantation of a glaucoma drainage device.
Read MoreUC Davis Health’s departments of orthopedic surgery, endocrinology, rheumatology and geriatric care have teamed up to create a multidisciplinary Fragility Fracture Program. The goal is to ensure patients who suffer a fragility fracture receive comprehensive treatment to prevent future fractures from happening.
Read MoreA diverse physician workforce — one that looks like the patient population — can help improve health equity. But a new study of residency programs in the U.S. found ophthalmology programs rank last in underrepresented minorities compared to other specialties.
Read MoreThe International Society for Pediatric and Adolescent Diabetes has released its clinical consensus guidelines on the treatment of diabetic ketoacidosis (DKA). It was published in the journal of Pediatric Diabetes. Nicole Glaser was the lead author of the published guidelines.
Read MoreAs the population over age 65 increases exponentially, so does the specialized care they require. To address these unique needs, UC Davis Health has added the nation’s first vice chair for geriatric emergency medicine and wellness.
Read MoreA new study by researchers at UC Davis Children’s Hospital uses the first randomized controlled trial to evaluate PC-CARE’s effectiveness for children with challenging behaviors and their parents or caregivers. The study’s findings were recently published in the Journal of Child Psychiatry Human Development.
Read MoreThree babies have been born after receiving the world’s first spina bifida treatment combining surgery with stem cells. This was made possible by a landmark clinical trial at UC Davis Health known formally as the “CuRe Trial: Cellular Therapy for In Utero Repair of Myelomeningocele.”
Read More